Glow Lifetech Corp. (GLWLF)
USD 0.04
(1.78%)
USD 0.04
(1.78%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -505.62 Thousand CAD | 12.15% |
| 2022 | -434.24 Thousand USD | -1165.88% |
| 2021 | -34.3 Thousand USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 19.42 Thousand USD | 113.21% |
| 2024 Q2 | 19.55 Thousand USD | 40.43% |
| 2023 FY | -381.49 Thousand USD | 12.15% |
| 2023 Q4 | -150.33 Thousand USD | -140.7% |
| 2023 Q3 | -62.45 Thousand USD | -27.98% |
| 2023 Q2 | -48.8 Thousand USD | -8.03% |
| 2023 Q1 | -45.17 Thousand USD | 88.36% |
| 2022 Q4 | -387.98 Thousand USD | -2419.4% |
| 2022 FY | -434.24 Thousand USD | -1165.88% |
| 2022 Q3 | -15.4 Thousand USD | 6.6% |
| 2022 Q2 | -16.48 Thousand CAD | -2.34% |
| 2022 Q1 | -16.11 Thousand CAD | -66.14% |
| 2021 Q1 | - CAD | 100.0% |
| 2021 Q4 | -9697.50 CAD | 0.0% |
| 2021 FY | -34.3 Thousand USD | 0.0% |
| 2021 Q3 | - CAD | 0.0% |
| 2021 Q2 | - CAD | 0.0% |
| 2020 Q4 | -1197.72 CAD | -204.66% |
| 2020 FY | - USD | 0.0% |
| 2020 Q3 | 1144.43 CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q2 | - CAD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bioxytran, Inc. | -8285.00 USD | -6002.897% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 103.371% |
| Institute of Biomedical Research Corp. | - USD | Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 105.163% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | 869.269% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 104.319% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 100.425% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | -1380.6% |
| Marizyme, Inc. | 457.7 Thousand USD | 210.47% |
| Genus plc | 178.7 Million USD | 100.283% |
| Pharming Group N.V. | 220.1 Million USD | 100.23% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | 912.562% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 223.274% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | -4496.591% |
| ContraFect Corporation | -154 Thousand USD | -228.328% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | 758.7% |
| IMV Inc. | -962.29 Thousand USD | 47.457% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | -30.484% |
| ONE Bio Corp. | 20.12 Million USD | 102.512% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 101.256% |
| Mesoblast Limited | -35.16 Million USD | 98.562% |
| MultiCell Technologies, Inc. | 49.32 USD | 1025292.62% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 101.79% |
| Genscript Biotech Corporation | 409.55 Million USD | 100.123% |
| Neon Bloom, Inc. | - USD | Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | Infinity% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | 16399.968% |
| Biomind Labs Inc. | -15.42 Thousand USD | -3178.17% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 55.708% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | 822.321% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | -306.938% |
| GlobeStar Therapeutics Corporation | - USD | Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | -10110.521% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | -911.25% |
| Arch Therapeutics, Inc. | -2439.00 USD | -20630.832% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | 459.875% |
| Accustem Sciences Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | 1133.998% |
| Q BioMed Inc. | -8988.00 USD | -5525.556% |
| GB Sciences, Inc. | -624.00 USD | -80929.647% |
| Alpha Cognition Inc. | -86.02 Thousand USD | -487.745% |
| CSL Limited | 7.56 Billion USD | 100.007% |
| Agentix Corp. | - USD | Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 101.14% |
| Enzolytics Inc. | 30.7 Thousand USD | 1746.558% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 204.807% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | -418.51% |
| argenx SE | 1.1 Billion USD | 100.046% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 98.04% |
| HST Global, Inc. | - USD | Infinity% |
| Enzon Pharmaceuticals, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | - USD | Infinity% |
| Halberd Corporation | -208.00 USD | -242988.942% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 1.727% |
| Inhibitor Therapeutics, Inc. | - USD | Infinity% |
| Zenith Capital Corp. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | Infinity% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | -5609.406% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 181.898% |
| WPD Pharmaceuticals Inc. | - USD | Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | -503.019% |
| Ember Therapeutics, Inc. | - USD | Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 151.178% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 105.261% |
| Kadimastem Ltd | -630.13 Thousand USD | 19.76% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | 15.42 Million USD | 103.278% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | - USD | Infinity% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| LadRx Corporation | -11.83 Thousand USD | -4172.286% |
| Cell Source, Inc. | - USD | Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | -947.732% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 386.376% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | 386.376% |
| Affymax, Inc. | 1.35 Million USD | 137.257% |
| Mobile Lads Corp. | - USD | Infinity% |
| Itoco Inc. | - USD | Infinity% |
| Rasna Therapeutics, Inc. | - USD | Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 110.973% |
| CytoDyn Inc. | -29 Thousand USD | -1643.534% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | - USD | Infinity% |
| Qrons Inc. | - USD | Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 212.35% |
| SYBLEU INC | 11.69 Thousand USD | 4423.059% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | -58.252% |
| Rebus Holdings, Inc. | - USD | Infinity% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | - USD | Infinity% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | - USD | Infinity% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | - USD | Infinity% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | - USD | Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | -35.556% |
| Neutra Corp. | 14.33 Thousand USD | 3627.206% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -516.616% |
| PureTech Health plc | -1.6 Million USD | 68.458% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 49.5% |
| IXICO plc | 3.27 Million USD | 115.463% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 27.143% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 71.769% |
| CSL Limited | 7.7 Billion USD | 100.007% |
| Cellectis S.A. | 18 Thousand USD | 2909.028% |